Shenzhen Hemei Group Co.,LTD. (SHE:002356)
China · Delayed Price · Currency is CNY 3.210
+0.030 (0.94%)
Aug 8, 2025, 1:45 PM CST
Sage Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 538.94 | 404.69 | 160.67 | 156.68 | 325.8 | 452.33 | Upgrade |
Other Revenue | 1.89 | 1.89 | 4.32 | 5.69 | 7 | 14.21 | Upgrade |
| 540.83 | 406.58 | 164.99 | 162.37 | 332.79 | 466.54 | Upgrade | |
Revenue Growth (YoY) | 261.64% | 146.43% | 1.61% | -51.21% | -28.67% | -45.01% | Upgrade |
Cost of Revenue | 498.28 | 371.95 | 95.8 | 99.08 | 236.68 | 337.97 | Upgrade |
Gross Profit | 42.55 | 34.63 | 69.18 | 63.29 | 96.11 | 128.56 | Upgrade |
Selling, General & Admin | 121.29 | 113.99 | 103.15 | 116.2 | 171.86 | 226.16 | Upgrade |
Research & Development | - | - | - | 0.8 | 7.28 | 12.97 | Upgrade |
Other Operating Expenses | 3.56 | 3.39 | 1.6 | 2.62 | 2.7 | 4.13 | Upgrade |
Operating Expenses | 127.3 | 119.48 | 104.99 | 146.87 | 264.2 | 263.02 | Upgrade |
Operating Income | -84.75 | -84.86 | -35.81 | -83.58 | -168.08 | -134.45 | Upgrade |
Interest Expense | - | - | - | - | -177.78 | -249.93 | Upgrade |
Interest & Investment Income | 26.6 | 27.08 | 28.09 | 2.85 | 2,171 | 73.29 | Upgrade |
Currency Exchange Gain (Loss) | -0.2 | -0.2 | 0.08 | 0.31 | -0.96 | 0.28 | Upgrade |
Other Non Operating Income (Expenses) | -2.11 | -2.04 | -3.18 | -0.91 | -8.94 | -263.05 | Upgrade |
EBT Excluding Unusual Items | -60.46 | -60.01 | -10.83 | -81.34 | 1,815 | -573.86 | Upgrade |
Gain (Loss) on Sale of Investments | 0.78 | 0.61 | - | -3.93 | -0.96 | -27.13 | Upgrade |
Gain (Loss) on Sale of Assets | 0.15 | 0.15 | 0.13 | 0 | 1.54 | 5.09 | Upgrade |
Asset Writedown | -0.52 | -0.52 | -0.5 | -6.43 | -0.87 | -0.36 | Upgrade |
Legal Settlements | -27.23 | -27.23 | -47.25 | 26.93 | -937.98 | -74.37 | Upgrade |
Other Unusual Items | 35.4 | 35.25 | 7.68 | -0.54 | 14.58 | -77.74 | Upgrade |
Pretax Income | -51.89 | -51.75 | -50.77 | -65.3 | 891.13 | -748.37 | Upgrade |
Income Tax Expense | -1.52 | -1.52 | - | - | 0.08 | 0.67 | Upgrade |
Earnings From Continuing Operations | -50.37 | -50.23 | -50.77 | -65.3 | 891.05 | -749.04 | Upgrade |
Minority Interest in Earnings | 6.6 | 6.54 | 3.57 | 3.62 | 8.8 | 245.04 | Upgrade |
Net Income | -43.76 | -43.69 | -47.2 | -61.68 | 899.85 | -504 | Upgrade |
Net Income to Common | -43.76 | -43.69 | -47.2 | -61.68 | 899.85 | -504 | Upgrade |
Shares Outstanding (Basic) | 1,309 | 1,312 | 1,311 | 1,312 | 1,311 | 1,311 | Upgrade |
Shares Outstanding (Diluted) | 1,309 | 1,312 | 1,311 | 1,312 | 1,311 | 1,311 | Upgrade |
Shares Change (YoY) | -0.01% | 0.05% | -0.09% | 0.09% | 0.00% | 148.41% | Upgrade |
EPS (Basic) | -0.03 | -0.03 | -0.04 | -0.05 | 0.69 | -0.38 | Upgrade |
EPS (Diluted) | -0.03 | -0.03 | -0.04 | -0.05 | 0.69 | -0.38 | Upgrade |
Free Cash Flow | -164.93 | -195.86 | -15.04 | -28.61 | -22.26 | 31.58 | Upgrade |
Free Cash Flow Per Share | -0.13 | -0.15 | -0.01 | -0.02 | -0.02 | 0.02 | Upgrade |
Gross Margin | 7.87% | 8.52% | 41.93% | 38.98% | 28.88% | 27.56% | Upgrade |
Operating Margin | -15.67% | -20.87% | -21.70% | -51.48% | -50.51% | -28.82% | Upgrade |
Profit Margin | -8.09% | -10.75% | -28.61% | -37.99% | 270.39% | -108.03% | Upgrade |
Free Cash Flow Margin | -30.50% | -48.17% | -9.12% | -17.62% | -6.69% | 6.77% | Upgrade |
EBITDA | -75.16 | -75.79 | -28.85 | -73.92 | -155.13 | -118.57 | Upgrade |
EBITDA Margin | -13.90% | -18.64% | -17.49% | -45.53% | -46.61% | -25.41% | Upgrade |
D&A For EBITDA | 9.59 | 9.06 | 6.96 | 9.66 | 12.95 | 15.89 | Upgrade |
EBIT | -84.75 | -84.86 | -35.81 | -83.58 | -168.08 | -134.45 | Upgrade |
EBIT Margin | -15.67% | -20.87% | -21.70% | -51.48% | -50.51% | -28.82% | Upgrade |
Effective Tax Rate | - | - | - | - | 0.01% | - | Upgrade |
Revenue as Reported | 540.83 | 406.58 | 164.99 | 162.37 | 332.79 | 466.54 | Upgrade |
Advertising Expenses | - | 2.13 | 0.59 | 0.9 | 0.66 | 0.86 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.